Human Blood and Immune Cells for Cell Therapy Research

Well-characterised starting material is an important foundation for cell therapy research and process development. Tebubio provides access to human blood, peripheral blood mononuclear cells (PBMCs) and pre-isolated immune-cell populations for research workflows ranging from immune profiling and cell isolation to activation, expansion and cell engineering.

The right starting material depends on your target cell population, donor requirements and downstream application.

Choose Your Cell Therapy Starting Material:

Whole blood: when you need a versatile source of immune cells or want to perform isolation from the original blood sample.
Human leukopaks: when you need a concentrated source of blood-derived cells for downstream PBMC isolation, immune-cell enrichment or cell therapy research.
PBMCs: when you need a broad population of mononuclear immune cells for downstream research.
Isolated immune cells: when you already know the target cell population and want to start directly with a defined primary cell population.
Healthy donor samples: when baseline immune biology, controls or process development are required.
Disease-state samples: when disease-associated immune characteristics are relevant to your research.

How to Select the Right Starting Material

Your starting material can determine the cell populations available for downstream isolation, activation, engineering and expansion.

Starting material When to consider it Next workflow step
Whole blood Immune profiling, cell isolation, assay development PBMC isolation / immune-cell isolation
Leukopaks PBMC isolation, immune-cell isolation, cell therapy research Cell isolation / enrichment
PBMCs T-cell and NK-cell research, immune profiling, activation Cell isolation / activation
Isolated T cells T-cell activation, expansion, cell engineering Activation / engineering
Isolated NK cells NK-cell activation, expansion, engineering and functional studies Activation / expansion
Other primary immune cells Immune profiling, disease modelling, functional studies Culture / assay / analysis
Disease-state samples Disease modelling, patient-relevant research. Process development to manufacturing transition. Isolation / profiling / process development

Whole Blood for Cell Therapy Research

Human whole blood provides a versatile starting material for researchers who need to isolate immune cells or analyse immune populations directly in their native blood matrix.

Whole blood can support:

Immune profiling
Cell isolation
Assay development
Flow cytometry and immunophenotyping
Downstream PBMC isolation

Healthy Donor Blood

Healthy donor blood can provide baseline material for immune-cell characterisation, method development, process development and experimental controls.

It can also be used to establish reference populations before introducing disease-associated biological variability.

Disease-State Blood

Disease-state blood can help researchers investigate disease-associated immune phenotypes and stress-test experimental workflows using biologically relevant samples.

Availability can depend on the disease area, donor characteristics and required sample specifications.

Looking for a specific donor or disease profile?

Discuss a Custom Sample Request

Leukopaks for Cell Therapy Research

Leukopaks provide a concentrated source of human blood-derived cells and can serve as a starting material for downstream immune-cell isolation and cell therapy research.

They can be particularly relevant for workflows requiring larger numbers of starting cells before isolation, activation, expansion or cell engineering.

Leukopaks can support:

PBMC isolation
Immune-cell isolation
T-cell and NK-cell research
Cell activation and expansion
Cell engineering research
CAR-T and CAR-NK research
Process development

Human Leukopaks

Leukopak availability can depend on donor characteristics, collection specifications, sample format and other sourcing requirements.

Discuss Your Leukopak Requirements?

Discuss Your Leukopak Requirements

PBMCs for Cell Therapy Research

Peripheral blood mononuclear cells (PBMCs) provide a widely used starting population for immune-cell research and cell therapy workflows.

PBMCs contain multiple immune-cell populations, including T cells, B cells, NK cells and monocytes, making them suitable for both broad immune profiling and downstream cell isolation.

Tebubio provides access to human PBMC products in formats suited to research applications, including cryopreserved options.

PBMCs can support:

T-cell research
NK-cell research
Immune profiling
Cell activation and expansion
Cell engineering
Cell isolation and enrichment
CAR-T and other immune-cell therapy research

Human PBMC Products

Explore human peripheral blood mononuclear cells for immune-cell research, profiling, activation, engineering and other cell-based applications.

For workflows requiring a specific donor profile, disease background or sample specification, custom sourcing options may also be available.

Discuss Your PBMC Requirements

Isolated Primary Immune Cells

When downstream research requires a defined immune-cell population, starting directly with isolated primary cells can reduce upstream processing and allow researchers to focus on activation, engineering, expansion or functional analysis.

Depending on the supplier and donor requirements, available populations can include:

T cells
CD4+ T cells
CD8+ T cells
NK cells
B cells
Monocytes
Other primary immune-cell populations

NK Cells for Cell Therapy Research

Primary NK cells can provide a defined starting population for studies focused on NK-cell activation, expansion and cytotoxic function.

B Cells for Immune-Cell Research

Isolated human B cells provide a defined primary immune-cell population for research focused on B-cell biology, immune-cell characterisation and functional studies.

They can also support broader immunology and disease-relevant research where a defined B-cell population is required.

Monocytes for Cell Therapy and Immunology Research

Isolated human peripheral blood monocytes can support research in immunology, immune-cell characterisation, disease modelling and functional studies.

Tebubio offers cryopreserved human peripheral blood monocytes isolated from healthy donors.

Other Primary Immune Cells

Additional blood-derived primary immune-cell populations can support immunology, disease modelling and cell therapy research.

For example, Tebubio offers cryopreserved human peripheral blood monocytes isolated from healthy donors.

Healthy Donor or Disease-State Samples

The appropriate starting material depends on the research question and the stage of development.

Healthy Donor Samples

Healthy donor samples can be used for:

Baseline immune biology
Method development
Process development
Process optimisation
Experimental controls
Immune-cell isolation and characterisation

They can provide a defined reference population before researchers introduce disease-associated biological variability.

Disease-State Samples

Disease-state blood and PBMCs can support research requiring disease-relevant immune biology.

Potential applications include:

Disease modelling
Process testing before manufaturing
Patient-relevant research
Immune phenotype characterisation
Comparison of healthy and disease-associated immune responses

Disease-state sample availability may depend on the required disease, donor characteristics, treatment history and sample format.

Need a specific disease-state or donor profile?

Discuss Your Sample Requirements

Need a Specific Starting Material?

The right biological starting material depends on your target population, donor requirements, disease background, processing format and downstream application.

Whether you need healthy donor blood, disease-state PBMCs, isolated T cells or another primary immune-cell population, Tebubio can help identify available options and discuss specific sourcing requirements. 

Looking for a defined donor profile or custom collection?

From Starting Material to Cell Therapy Research

Starting material is the first stage of a broader cell therapy workflow. Once the required population has been obtained, researchers may need to isolate or enrich specific cell subsets before activation, genetic engineering and expansion.

Tebubio can support the next stages of the workflow with:

Frequently Asked Questions

  • What are cell therapy starting materials?

    Cell therapy starting materials are biological materials used as the starting point for downstream cell therapy research and process development. They can include human whole blood, peripheral blood mononuclear cells (PBMCs) and isolated primary immune-cell populations such as T cells, NK cells, B cells and monocytes.

  • What are PBMCs used for in cell therapy research?

    Peripheral blood mononuclear cells (PBMCs) provide a heterogeneous population of immune cells that can be used for immune profiling, cell isolation, activation, expansion and cell engineering research. PBMCs can also serve as a starting population for workflows involving T-cell and NK-cell therapies, including CAR-T and CAR-NK research.

  • What is the difference between whole blood and PBMCs?

    Whole blood contains red blood cells, white blood cells, platelets and plasma, while PBMCs are a specific fraction of blood containing mononuclear immune cells, including lymphocytes and monocytes. Whole blood can be used directly for certain research applications or as a starting material for PBMC isolation, while PBMCs provide a more defined starting population for downstream immune-cell research.

  • Can I source healthy donor and disease-state blood or PBMCs?

    Availability can depend on the required donor characteristics, disease background, sample format and other specifications. Tebubio provides access to human blood and PBMC products, with sourcing options that can support both healthy donor research and disease-relevant applications. For specific donor or disease requirements, please contact our team to discuss your needs.

  • Which primary immune cells can be used for cell therapy research?

    Depending on the available product and donor specifications, primary immune-cell starting materials can include T cells, CD4+ T cells, CD8+ T cells, NK cells, B cells and monocytes. These isolated populations can be used for downstream applications such as activation, expansion, cell engineering and functional studies.

  • Can PBMCs or isolated immune cells be used for CAR-T and CAR-NK research?

    Yes. PBMCs and isolated primary immune cells can serve as starting populations for research workflows involving engineered immune cells. Depending on the experimental design, researchers may work with PBMCs, purified T cells or NK cells before downstream activation, genetic engineering and expansion.